Oral ketoconazole (Nizoral, etc) will continue to fall out of favor for fungal infections
September 2013
Oral ketoconazole (Nizoral, etc) will continue to fall out of favor for fungal infections...due to stronger labeling restrictions.
It's no longer approved for skin infections due to the risk of hepatotoxicity, adrenal insufficiency, and serious drug interactions.
And it will probably be withdrawn in Europe.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote